Complexity in research and development (R&D) will only increase as the life sciences industry advances precision medicine, with the availability and adoption of new technologies impacting the entire pharmaceutical value chain. In this webinar, our expert presenters will share insights into the how the industry must evolve beyond traditional ways of working to better meet patient needs in our hyper-connected, ever-changing world.

This interactive session will touch on digitalization’s impact on the drug lifecycle, from leveraging data to infuse innovation into the discovery process, to transforming commercialization to bring a drug to market more quickly – all while keeping the patient at the center. The presenters will discuss the value of digitalization across:

  • Early drug discovery
  • Manufacturing
  • Clinical development
  • Regulatory and safety
  • Commercial   
The webinar will provide pharma and biotech executives with steps they can take to maximize the value of digitalization within their organizations. Attendees will also benefit from a question and answer session.

Featured Speakers

Bernard Panes

Solution Architect
Digital Solution Design, Accenture

Bernard is a Solution Architect within Accenture's Digital practice with a focus on Analytics and Artificial Intelligence in life sciences, where he works out how we deliver complex transformation programs. The sweet spot for Bernard is the intersection between business value, architectural approaches, and how controlled change is delivered in an iterative, realistic, and value focused way.

Andrew Finlayson

Digital Transformation Lead
Accenture Interactive

Andrew’s role as an Accenture Interactive Managing Director specialising in digital innovation within the Life Sciences industry allows his fulfil his desire to help organisations change the way the world works by harnessing the power of digital to improve their businesses and improve patient outcomes.

NOW AVAILABLE ON-DEMAND

Register now for this webinar